Growth hormone treatment of children with chronic renal insufficiency, end-stage renal disease and following renal transplantation - Update 1997

Journal of Pediatric Endocrinology and Metabolism

Volumn 10, Issue 4, 1997, Pages 361-370

  Fine, Richard N ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ACIDOSIS; CHILD; CHRONIC KIDNEY FAILURE; DIALYSIS; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HORMONAL THERAPY; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MULTICENTER STUDY; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEODYSTROPHY; REVIEW;

ADOLESCENT; BONE DISEASES; CHILD; CHILD, PRESCHOOL; GLUCOSE INTOLERANCE; GROWTH; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION;

EID: 0030760467     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Guthrie LG, Oxon MD. Chronic interstitial nephritis in childhood. Lancet 1897; 2: 585.
2. Tönshoff B, Fine RN. Growth and growth hormone treatment in children with chronic renal insufficiency. In: Nissenson AR, Fine RN, Gentile DE, eds, Clinical Dialysis. East Norwalk, CT: Appleton and Lange, 1995; 549-573.
3. Mehls O, Ritz E. Skeletal growth in experimental uremia. Kidney Int 1983; 21(Suppl): S53-S62.
4. Lippe B, Fine RN, Koch VH, Sherman BM. Accelerated growth following treatment of children with chronic renal failure with recombinant human growth hormone (Somatrem): A preliminary report. Acta Paediatr Scand 1988; 343 (Supp): 127-131.
5. Koch VH, Lippe BM, Nelson PA, Boechat MI, Sheman BM, Fine RN. Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure. J Pediatr 1989; 115: 365-371.
6. Hokken-Koelega ACS, Stijnen T, De Muinck Keizer-Schrama SMPF, Wit JM, Wolff ED, De Jong MCJW, Donckerwolcke RA, Abbad NCB, Bot A, Blum WF, Drop SLS. Placebo-controlled, double-blind, crossover trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 1991; 338: 585-590.
7. Fine RN, Kohaut EC, Brown D, Perlman AJ, for the Genentech Cooperative Study Group. Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebo-controlled study. J Pediatr 1994; 124: 374-382.
8. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). 1996 Annual Report.
9. Hokken-Koelega ACS, van Zaal MAE, van Bergen W, et al: Final height and its predictive factors after renal transplantation in childhood. Pediatr Res 1994; 36: 323-328.
10. Fine RN, Kohaut E, Brown D, Kuntze J, Attie KM. Long term (5 year) treatment of growth retarded children with chronic renal insufficiency (CRI), with recombinant human growth hormone (rhGH). Kidney Int 1996; 49: 781-785.
11. Fine RN, Attie KM, Kuntze J, Brown DF, Kohaut EC, for the Genentech Collaborative Study Group. Recombinant human growth hormone in infants and young children with chronic renal insufficiency. Pediatr Nephrol 1995; 9: 451-457.
12. Fine RN, Brown DF, Kuntze J, Wooster P, Kohaut EE. Growth following discontinuation of recombinant human growth hormone (rhGH) in children with chronic renal insufficiency (CRI). J Pediatr 1996; 129: 883-891.
13. Saenger P, Attie MA, Dimartino-Nardi J, Fine RN, and the Genentech Collaborative Group. Parameters of carbohydrate metabolism after five years of growth hormone therapy in children with chronic renal insufficiency compared with growth hormone deficiency, Turner syndrome and idiopathic short stature. Pediatr Nephrol 1995; 10: 261-263.
14. Watkins SL. Is severe renal osteodystrophy a contraindication for recombinant human growth hormone treatment. Pediatr Nephrol 1996; 10: 351-354.
15. Watkins SL, Johanson A, Winters W, Avner ED. Legg-Perthes in children with chronic renal failure during growth. J Am Soc Nephrol 1990; 1: 344 (abstract).
16. Mehls O, Broyer M on behalf of the European/ Australian Study Group. Growth response to recombinant human growth hormone in short prepubertal children with chronic renal failure with or without dialysis. Acta Paediatr Scand 1994; (Suppl) 399: 81-87.
17. Boechat MI, Watkins SL. Avascular necrosis in children with chronic renal disease. Pediatr Radiol 1995; 25:676 (abstract).
18. Fine RN, Yadin O, Moulton L, Nelson PA, Boechat MI, Lippe BM. Five years experience with recombinant human growth hormone treatment of children with chronic renal failure. J Pediatr Endocrinol 1994;7:1-12.
19. Tönshoff B, Mehls O, Heinrich U, Blum WF, Ranke MB, Schauer A. Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr 1990; 116: 561-566.
20. Schaefer F, Wuhl E, Haffher D, Mehls O and the German Group for Growth Hormone Treatment in Chronic Renal Failure. Stimulation of growth by recombinant human growth hormone in children undergoing peritoneal or hemodialysis treatment. Adv Perit Dial 1994; 10: 321-326.
21. Glastre C,. Berard E. Cochat P and la Societe de Nephrologie Pediatrique. Effect of recombinant growth hormone on growth in children on dialysis. Pediatr Nephrol 1994; 8: C8.
22. Wuhl E, Haffner D, Nissel R, Schaefer F, Mehls O, German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Short dialyzed children respond less to growth hormone than patients prior to dialysis. Pediatr Nephrol 1996; 10: 294-298.
23. Rees L, Rigden SPA, Ward G, Preece MA. Treatment of short stature in renal disease with recombinant human growth hormone. Arch Dis Child 1990; 65: 856-860.
24. Johansson G, Sietnieks A, Janssens F, et al: Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation with functioning renal transplants: an interim report on five European studies. Acta Paediatr Scand 1990; 370: 36-42.
25. Fine RN, Yadin O, Nelson PA, et al: Recombinant human growth hormone treatment of children following renal transplantation. Pediatr Nephrol 1991; 5: 147-151.
26. Tönshoff B, Dietz M, Haffner D, et al. Effects of two years of growth hormone treatment in short children with renal disease. Acta Paediatr Scand 1991; 379: 33-41.
27. van Es A, on behalf of the European Study Group. Growth hormone treatment in short children with chronic renal failure and after renal transplantation: Combined data from European clinical trials. Acta Paediatr Scand 1991; 379: 42-48.
28. van Dop C, Jabs KL, Donohoue PA, et al. Accelerated growth rates in children treated with growth hormone after renal transplantation. J Pediatr 1992; 120: 242-250.
29. Bartosh S, Kaiser B, Rezvani I, et al. Effects of growth hormone administration in pediatric renal recipients. Pediatr Nephrol: 1992; 6: 68-73.
30. Fine RN, Yadin O, Moulten L, et al. Extended recombinant human growth hormone treatment after renal transplantation in children. J Am Soc Nephrol 1992: 3; 274-283.
31. Benfield MR, Parker KL, Waldo FB, et al. Treatment of growth failure in children after renal transplantation. Transplantation 1993; 55: 305-308.
32. Janssen F, Van Damme-Lombaerts R, Van Dyck M, et al. Effects of recombinant human growth hormone on graft function in renal-transplanted children and adolescents: The three-year experience of a Belgian study group. Transplant Proc 1993; 25: 1049-1050.
33. Jabs K, van Dop C, Harmon WE. Growth hormone treatment of growth failure among children with renal transplants. Kidney Int 1993; 44: S71-S75.
34. Tönshoff B, Haffner D, Mehls O, et al. Efficacy and safety of growth hormone treatment in children with renal allografts: Three year experience. Kidney Int 1993; 44: 199-207.
35. Hokken-Koelega ACS, Stijnen T, deJong MCJW, et al. A placebo-controlled double-blind trial of growth hormone treatment in prepubertal children with renal allografts. Vorden, The Netherlands: Grafitel-Veldwijk, 1994; 125-140.
36. Broyer M, Guest G, Crosnier H, et al. A multicenter open randomized controlled study of rhGH therapy in short children after kidney transplantation. JASN 1995; 6: 1075.
37. Hokken-Koelega ACS, Stijnen T, deRidder MAJ, et al. Impressive growth with growth hormone therapy in severely growth-retarded adolescents after renal transplantation. Lancet 1994; 343: 1313-1317.
38. Schwartz DI, Warady BA, Buchanan CL, et al. "Low-dose" growth hormone therapy during peritoneal dialysis or following renal transplantation. Pediatr Nephrol 1995:9: 320-324.
39. Chavers BM, Doherty L, Nevins TE, et al. Effects of growth hormone on kidney function in pediatric transplant recipients. Pediatr Nephrol 1995; 9: 176-181.
40. Maxwell H, Dalton RN, Nair DR, et al. Effects of recombinant human growth hormone on renal function in children with renal transplants. J Pediatr 1996; 128: 177-183.
41. Tyden G, Berg U, Reinholt F. Acute renal graft rejection after treatment with human growth hormone. Lancet: 1990; 336: 1455-1456.
42. Schwartz: Cadaveric renal allograft rejection after treatment with recombinant human growth hormone. J Pediatr 1992; 120: 244-250.
43. Hokken-Koelega ACS, Stijnen T, de Muinck Keizer-Schrama SMPF, et al. Levels of growth hormone, insulin-like growth fector I (IFG-I) and II, IGF-binding protein-1 and 3, and cortisol in prednisone-treated children with growth retardation after renal transplantation. J Clin Endocrinol Metab 1993; 77: 932-938.
44. Kovacs G, Fine RN, Worgall S, et al. Growth hormone prevents steroid-induced growth depression in health and uremia. Kidney Int 1991; 40: 1032-1040.
45. Tönshoff B, et al. Deconvolution Analysis of Spontaneous nocturnal growth hormone secretion in prepubertal children with preterminal chronic renal failure and with end-stage renal disease. Pediatr Res 1995; 37: 86-93.